| DM |
2026-09-24 20:24 |
2026-09-23 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
D - Sale to Iss |
— |
-189.8K |
0 |
-100% |
— |
|
2026-08-24 18:04 |
2026-08-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$16.95 |
-6,258 |
189.8K |
-3% |
-$106.1K |
|
2026-06-23 17:49 |
2026-06-19 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
A - Grant |
$0.00 |
+18.8K |
196.1K |
+11% |
$0 |
|
2026-05-22 18:22 |
2026-05-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$16.55 |
-6,827 |
177.3K |
-4% |
-$113.0K |
|
2026-02-24 |
2026-02-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$19.66 |
-16.9K |
184.2K |
-8% |
-$331.3K |
|
2025-11-24 |
2025-11-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$17.90 |
-6,989 |
201.0K |
-3% |
-$125.1K |
|
2025-08-22 |
2025-08-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$13.39 |
-6,989 |
208.0K |
-3% |
-$93.6K |
|
2025-05-21 |
2025-05-19 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
A - Grant |
$0.00 |
+10.4K |
224.7K |
+5% |
$0 |
|
2025-05-21 |
2025-05-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$9.45 |
-9,701 |
215.0K |
-4% |
-$91.7K |
|
2025-03-04 |
2025-02-28 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
A - Grant |
$0.00 |
+75.0K |
214.3K |
+54% |
$0 |
|
2025-02-24 |
2025-02-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$9.66 |
-11.3K |
139.3K |
-8% |
-$109.1K |
|
2024-11-22 |
2024-11-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$9.97 |
-10.1K |
150.6K |
-6% |
-$100.5K |
|
2024-08-22 |
2024-08-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$8.22 |
-5,201 |
160.6K |
-3% |
-$42.8K |
|
2024-05-22 |
2024-05-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$9.10 |
-5,201 |
165.8K |
-3% |
-$47.3K |
|
2024-04-04 |
2024-04-02 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
A - Grant |
$0.00 |
+37.5K |
171.0K |
+28% |
$0 |
|
2024-02-22 |
2024-02-20 |
TBPH |
Theravance Biopharma, Inc. |
Miller Aine |
SVP, DEV, HEAD OF IRE OFFICE |
F - Tax |
$8.92 |
-11.8K |
133.5K |
-8% |
-$105.1K |